Marksans Pharma Limited announced that at its Board of Directors meeting held on May 30, 2024, recommended a final dividend of INR 0.60 per Equity Share (face value INR 1 per share) for the financial year 2023-24. The dividend, if approved by the Members at the forthcoming Annual General Meeting ("AGM") will be credited /dispatched within 30 days from the date of AGM.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159 INR | -0.03% | -2.28% | -1.28% |
05-31 | Transcript : Marksans Pharma Limited, Q4 2024 Earnings Call, May 31, 2024 | |
05-30 | INDIA STOCKS-Indian shares fall for fifth session on weak global cues, election uncertainties | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.28% | 865M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- MARKSANS Stock
- News Marksans Pharma Limited
- Marksans Pharma Limited Recommends Final Dividend for the Financial Year 2023-24